BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37749331)

  • 21. Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn's disease and ankylosing spondylitis.
    Ergin A; Syrbe U; Scheer R; Thiel A; Adam T; Büssow K; Duchmann R; Zeitz M; Sieper J
    J Clin Immunol; 2011 Dec; 31(6):998-1009. PubMed ID: 21901394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease.
    Fu SH; Chien MW; Hsu CY; Liu YW; Sytwu HK
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32403220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenicity of In Vivo Generated Intestinal Th17 Lymphocytes is IFNγ Dependent.
    Nizzoli G; Burrello C; Cribiù FM; Lovati G; Ercoli G; Botti F; Trombetta E; Porretti L; Todoerti K; Neri A; Giuffrè MR; Geginat J; Vecchi M; Rescigno M; Paroni M; Caprioli F; Facciotti F
    J Crohns Colitis; 2018 Jul; 12(8):981-992. PubMed ID: 29697763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical Role of CD6highCD4+ T Cells in Driving Th1/Th17 Cell Immune Responses and Mucosal Inflammation in IBD.
    Ma C; Wu W; Lin R; Ge Y; Zhang C; Sun S; Cong Y; Li X; Liu Z
    J Crohns Colitis; 2019 Mar; 13(4):510-524. PubMed ID: 30395204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
    Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
    Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crohn's Disease Patients Uniquely Contain Inflammatory Responses to Flagellin in a CD4 Effector Memory Subset.
    Morgan NN; Duck LW; Wu J; Rujani M; Thomes PG; Elson CO; Mannon PJ
    Inflamm Bowel Dis; 2022 Dec; 28(12):1893-1903. PubMed ID: 35931421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pathogenicity and Synergistic Action of Th1 and Th17 Cells in Inflammatory Bowel Diseases.
    Cao H; Diao J; Liu H; Liu S; Liu J; Yuan J; Lin J
    Inflamm Bowel Dis; 2023 May; 29(5):818-829. PubMed ID: 36166586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
    Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
    Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Microbiota Flagellins Drive Adaptive Immune Responses in Crohn's Disease.
    Alexander KL; Zhao Q; Reif M; Rosenberg AF; Mannon PJ; Duck LW; Elson CO
    Gastroenterology; 2021 Aug; 161(2):522-535.e6. PubMed ID: 33844987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tripartite motif-containing (TRIM) 21 negatively regulates intestinal mucosal inflammation through inhibiting T
    Zhou G; Wu W; Yu L; Yu T; Yang W; Wang P; Zhang X; Cong Y; Liu Z
    J Allergy Clin Immunol; 2018 Oct; 142(4):1218-1228.e12. PubMed ID: 29113905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.
    Ricciardelli I; Lindley KJ; Londei M; Quaratino S
    Immunology; 2008 Oct; 125(2):178-83. PubMed ID: 18422560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients.
    Veny M; Esteller M; Ricart E; Piqué JM; Panés J; Salas A
    Aliment Pharmacol Ther; 2010 Mar; 31(5):561-72. PubMed ID: 19958311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased frequency of intestinal CD4+ T cells reactive with mycobacteria in patients with Crohn's disease.
    Olsen I; Lundin KE; Sollid LM
    Scand J Gastroenterol; 2013 Nov; 48(11):1278-85. PubMed ID: 24131402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease.
    Kusugami K; Matsuura T; West GA; Youngman KR; Rachmilewitz D; Fiocchi C
    Gastroenterology; 1991 Dec; 101(6):1594-605. PubMed ID: 1683326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis.
    Spalinger MR; Kasper S; Chassard C; Raselli T; Frey-Wagner I; Gottier C; Lang S; Atrott K; Vavricka SR; Mair F; Becher B; Lacroix C; Fried M; Rogler G; Scharl M
    Mucosal Immunol; 2015 Jul; 8(4):918-29. PubMed ID: 25492475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mucosa-associated microbiota drives pathogenic functions in IBD-derived intestinal iNKT cells.
    Burrello C; Pellegrino G; Giuffrè MR; Lovati G; Magagna I; Bertocchi A; Cribiù FM; Boggio F; Botti F; Trombetta E; Porretti L; Di Sabatino A; Vecchi M; Rescigno M; Caprioli F; Facciotti F
    Life Sci Alliance; 2019 Feb; 2(1):. PubMed ID: 30760554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
    Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
    J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
    Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
    Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct profiles of effector cytokines mark the different phases of Crohn's disease.
    Zorzi F; Monteleone I; Sarra M; Calabrese E; Marafini I; Cretella M; Sedda S; Biancone L; Pallone F; Monteleone G
    PLoS One; 2013; 8(1):e54562. PubMed ID: 23349929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of CCR5+ T cells around RANTES+ granulomas in Crohn's disease: a pivotal site of Th1-shifted immune response?
    Oki M; Ohtani H; Kinouchi Y; Sato E; Nakamura S; Matsumoto T; Nagura H; Yoshie O; Shimosegawa T
    Lab Invest; 2005 Jan; 85(1):137-45. PubMed ID: 15492753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.